First Page | Document Content | |
---|---|---|
Date: 2017-06-02 05:25:57 | Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664Add to Reading ListSource URL: www.takara-bio.co.jpDownload Document from Source WebsiteFile Size: 478,76 KBShare Document on Facebook |